Dexamethasone, a type of corticosteroid, reduced skin thickening, inflammation, and the activity of genes that induce fibrosis (scarring) in a…
Articles by Andrea Lobo, PhD
Using combination therapy for pulmonary arterial hypertension (PAH) improves survival in people with systemic sclerosis (SSc), according to the…
Physiotherapist-guided telerehabilitation is more effective than self-managed at-home exercises in improving hand mobility and function in women with…
A CAR T-cell therapy being developed by Bristol Myers Squibb eased skin thickness and improved lung function in people…
The presence and severity of interstitial lung disease in people with systemic sclerosis (SSc) are associated with a specific…
Modifying mesenchymal stem cells (MSCs) — a type of stem cell found in various tissues and, in this case,…
The first patient with systemic sclerosis (SSc) has been dosed in a Phase 1 trial of Adicet Bio’s…
The Scleroderma Research Foundation (SRF) announced that it has joined Vie Ventures to advance research and accelerate the…
Most people with systemic sclerosis (SSc) have fibrosis, or scarring, that affects the heart muscle, a study in Australia…
Lung function decline among people with systemic sclerosis-associated interstitial lung disease (SSc-ILD) was significantly slowed over the course of about…